ClinicalTrials.govpublic full text
A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH
non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, nash - nonalcoholic steatohepatitis, nash, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 898878
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.